Skip to main content
FTRE
NASDAQ Industrial Applications And Services

Fortrea Q3 Beats Year-Ago Loss, Raises 2026 Guidance Midpoints

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$25.77
Mkt Cap
$2.461B
52W Low
$8.55
52W High
$26.16
52W Position info
201% above low
Off High info
1.5% below high
Rel. Volume info
2.3× avg
Market data snapshot near publication time

FTRE has more than doubled off its 52-week low of $8.55 on elevated volume (2.3× avg).

Summary

Fortrea reported Q3 2026 revenue of $691.5 million, a $0.6 million GAAP profit versus a $15.9 million loss a year ago, and raised the midpoints of its 2026 revenue and adjusted EBITDA guidance. It also cut backlog by $558 million to $7,316 million after a contract review, which it says does not affect guidance.

Updates

  1. · Reuters — Fortrea Holdings Inc reported quarterly adjusted earnings of 28 cents per share for the quarter ended September 30, versus the mean analyst expectation of 22 cents per share.

    • Revenue — Revenue fell 1.4% to $691.50 million; analysts expected $669.95 million.
    • Earnings Per Share — Reported EPS for the quarter was 1 cent. Adjusted EPS was 28 cents versus 12 cents a year earlier.
    • Net Income — Quarterly net income was $600 thousand.
    All 4 details
    • Revenue fell 1.4% to $691.50 million; analysts expected $669.95 million.
    • Reported EPS for the quarter was 1 cent.
    • Quarterly net income of $600 thousand.
    • Adjusted EPS 28 cents versus 12 cents a year earlier.

Key Events · Earnings and Guidance · FTRE

  • Q3 Profit Replaces Year-Ago Loss

    Revenue was $691.5 million versus $701.3 million a year earlier, but GAAP net income turned to $0.6 million ($0.01 per diluted share) from a $15.9 million loss.

  • Adjusted Earnings More Than Double

    Adjusted EBITDA rose to $58.0 million from $50.7 million, and adjusted diluted EPS rose to $0.28 from $0.12.

  • Backlog Cut by $558 Million

    A contract review reduced backlog to $7,316 million to reflect estimated scope and study delivery requirements, including inactive trials; the company says historical results and 2026 guidance are unaffected.

  • 2026 Guidance Midpoints Raised

    Full-year revenue guidance is now $2,665 million to $2,690 million and adjusted EBITDA $210 million to $218 million, with both ranges narrowed.


Analysis · FTRE · Industrial Applications And Services

Fortrea swung to a small GAAP profit and more than doubled adjusted net income year over year, and management raised the midpoints of both full-year revenue and adjusted EBITDA guidance while narrowing the ranges. The offsetting item is a $558 million cut to backlog, to $7,316 million, after a contract review covering scope and inactive trials; the company says it does not affect historical results or 2026 guidance, but it lowers the reported forward revenue base investors use to value the business. Book-to-bill of 1.12x and $52.5 million of quarterly free cash flow support the turnaround narrative that has driven the stock toward its 52-week high.

How filings like this one have moved

In the 30 days to Nov 12, 2026, 37% of the 3595 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, FTRE was trading at $25.77 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $2.5B. The 52-week trading range was $8.55 to $26.16. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

FTRE - Latest Insights

FTRE
Oct 29, 2026, 4:15 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $23.14
Real-time Price: $20.14 info
Change: -$3.00 (-13%) info
Market Cap: $1.936B info
FTRE
Oct 29, 2026, 6:30 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $25.80
Real-time Price: $20.14 info
Change: -$5.66 (-22%) info
Market Cap: $1.936B info
FTRE
Sep 10, 2026, 8:12 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $16.79
Real-time Price: $20.14 info
Change: +$3.35 (+20%) info
Market Cap: $1.936B info
FTRE
Sep 10, 2026, 7:00 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $16.79
Real-time Price: $20.14 info
Change: +$3.35 (+20%) info
Market Cap: $1.936B info
FTRE
Sep 02, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $17.72
Real-time Price: $20.14 info
Change: +$2.42 (+14%) info
Market Cap: $1.936B info